New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia

New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant recipients. Its development has also been shown to be associated with an adverse impact on patient survival and an increased risk of graft rejection and graft loss, as well as an increased incidence...

Full description

Bibliographic Details
Main Authors: Muntasir Mohammed Abdulrahman, Mohammed Abdulrahim Idris, Wadei F Elhakimi, Mahmood Akhtar, Montassir Hammam, Ahmed Abdulfattah Aldajani, Yousef Mohammed Aljamaan, Hassan Mohammed Alshahri, Abdulrahman Housawi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=863;epage=871;aulast=Abdulrahman
id doaj-69697f31a2174ff8a187d2e675fe8af1
record_format Article
spelling doaj-69697f31a2174ff8a187d2e675fe8af12020-11-25T00:16:00ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422018-01-0129486387110.4103/1319-2442.239641New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi ArabiaMuntasir Mohammed AbdulrahmanMohammed Abdulrahim IdrisWadei F ElhakimiMahmood AkhtarMontassir HammamAhmed Abdulfattah AldajaniYousef Mohammed AljamaanHassan Mohammed AlshahriAbdulrahman HousawiNew-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant recipients. Its development has also been shown to be associated with an adverse impact on patient survival and an increased risk of graft rejection and graft loss, as well as an increased incidence of infectious complications. The study aims to describe the incidence of NODAT and its important risk factors in a single center. We conducted a retrospective analysis of data from all kidney transplant recipients in our center, transplanted between September 2008 and May 2013. Out of 311 patients, 77 had diabetes mellitus (DM) before transplantation and were excluded, leaving 234 patients as the study population. NODAT was diagnosed based on the WHO definition for DM: any two readings of fasting blood sugar >7 mmol/L or random blood sugar >11 or the use of hypoglycemic medications after 1st posttransplant month. The mean age of the study patients was 36 years ± 14 years; 55.5% were male, 69% had living-related transplant, 31% had deceased donor transplant, 98% were on tacrolimus-based immunosuppression regimen, 2% on cyclosporine and all patients were on the steroid-based regimen. The 1 and 5-year cumulative incidence of NODAT was 14.1% and 27.5%, respectively. The median duration to onset of NODAT was 2.5 months. The body mass index of >30 kg/m2 and age >60 years at the time of transplant were significantly associated with the occurrence of NODAT. Our finding of incidence was not different from what has been reported in the literature. Larger prospective and multicenter studies are needed.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=863;epage=871;aulast=Abdulrahman
collection DOAJ
language English
format Article
sources DOAJ
author Muntasir Mohammed Abdulrahman
Mohammed Abdulrahim Idris
Wadei F Elhakimi
Mahmood Akhtar
Montassir Hammam
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Hassan Mohammed Alshahri
Abdulrahman Housawi
spellingShingle Muntasir Mohammed Abdulrahman
Mohammed Abdulrahim Idris
Wadei F Elhakimi
Mahmood Akhtar
Montassir Hammam
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Hassan Mohammed Alshahri
Abdulrahman Housawi
New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
Saudi Journal of Kidney Diseases and Transplantation
author_facet Muntasir Mohammed Abdulrahman
Mohammed Abdulrahim Idris
Wadei F Elhakimi
Mahmood Akhtar
Montassir Hammam
Ahmed Abdulfattah Aldajani
Yousef Mohammed Aljamaan
Hassan Mohammed Alshahri
Abdulrahman Housawi
author_sort Muntasir Mohammed Abdulrahman
title New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
title_short New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
title_full New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
title_fullStr New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
title_full_unstemmed New-onset diabetes after transplantation among renal transplant recipients at a new transplant center; King Fahad Specialist Hospital-Dammam, Saudi Arabia
title_sort new-onset diabetes after transplantation among renal transplant recipients at a new transplant center; king fahad specialist hospital-dammam, saudi arabia
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2018-01-01
description New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant recipients. Its development has also been shown to be associated with an adverse impact on patient survival and an increased risk of graft rejection and graft loss, as well as an increased incidence of infectious complications. The study aims to describe the incidence of NODAT and its important risk factors in a single center. We conducted a retrospective analysis of data from all kidney transplant recipients in our center, transplanted between September 2008 and May 2013. Out of 311 patients, 77 had diabetes mellitus (DM) before transplantation and were excluded, leaving 234 patients as the study population. NODAT was diagnosed based on the WHO definition for DM: any two readings of fasting blood sugar >7 mmol/L or random blood sugar >11 or the use of hypoglycemic medications after 1st posttransplant month. The mean age of the study patients was 36 years ± 14 years; 55.5% were male, 69% had living-related transplant, 31% had deceased donor transplant, 98% were on tacrolimus-based immunosuppression regimen, 2% on cyclosporine and all patients were on the steroid-based regimen. The 1 and 5-year cumulative incidence of NODAT was 14.1% and 27.5%, respectively. The median duration to onset of NODAT was 2.5 months. The body mass index of >30 kg/m2 and age >60 years at the time of transplant were significantly associated with the occurrence of NODAT. Our finding of incidence was not different from what has been reported in the literature. Larger prospective and multicenter studies are needed.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=863;epage=871;aulast=Abdulrahman
work_keys_str_mv AT muntasirmohammedabdulrahman newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT mohammedabdulrahimidris newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT wadeifelhakimi newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT mahmoodakhtar newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT montassirhammam newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT ahmedabdulfattahaldajani newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT yousefmohammedaljamaan newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT hassanmohammedalshahri newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
AT abdulrahmanhousawi newonsetdiabetesaftertransplantationamongrenaltransplantrecipientsatanewtransplantcenterkingfahadspecialisthospitaldammamsaudiarabia
_version_ 1725385347476488192